Your browser doesn't support javascript.
loading
[Study on the correlation between glycolipids and prostate volume in patients with benign prostatic hyperplasia].
Xiang, X P; Zhou, T; Li, S L; Zhu, X; Ding, L M; Ma, D M.
Affiliation
  • Xiang XP; Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
  • Zhou T; Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
  • Li SL; Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
  • Zhu X; Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
  • Ding LM; Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
  • Ma DM; Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 58(9): 1384-1387, 2024 Sep 06.
Article in Zh | MEDLINE | ID: mdl-39290021
ABSTRACT
To study the clinical correlation between fasting plasma glucose, lipid metabolism, prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia, and to explore the combined effect as diagnostic indicators. A total of 108 patients with benign prostatic hyperplasia treated in Beijing University of Chinese Medicine Third Affiliated Hospital from June 2021 to March 2023 were retrospectively analyzed as the hyperplasia group, and 98 healthy physical examination personnel were selected as the control group during the same period. Compare the differences in levels of fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), small and dense low-density lipoprotein cholesterol (sdLDL-C), homocysteine, lipoprotein a (LPa), prostate specific antigen (PSA), and free prostate specific antigen (fPSA) between two groups of patients. Using Pearson analysis method to analyze the correlation between the above indicators and the size of prostate volume in patients with benign prostatic hyperplasia; using multiple linear regression to analyze the influencing factors of prostate volume enlargement; draw receiver operating characteristic (ROC) curves and analyze the application value of individual and combined detection of HDL, FPG, PSA, and fPSA. The results showed that there were significant differences in HDL, FPG, PSA, and fPSA levels between the control group and the proliferative group(P<0.05). The size of prostate volume is negatively correlated with HDL(r=-0.183, P<0.05) and positively correlated with FPG (r=0.202, P<0.05), PSA(r=0.412, P<0.05), and fPSA(r=0.425, P<0.05). The results of multiple linear regression analysis showed that HDL(P=0.000), FPG(P=0.048), PSA(P=0.044), and fPSA (P=0.012) were risk factors for increased volume of benign prostatic hyperplasia; ROC curve analysis shows that the AUC of HDL, FPG, PSA, and fPSA combined detection is 0.823, which is better than individual detection. In conclusion,HDL, FPG, PSA, fPSA has close correlation with hyperplasia of prostate, the joint detection may has better prediction for benign prostatic hyperplasia.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Hyperplasia / Glycolipids / Prostate-Specific Antigen Limits: Humans / Male Language: Zh Journal: Zhonghua Yu Fang Yi Xue Za Zhi Year: 2024 Document type: Article Affiliation country: China Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Hyperplasia / Glycolipids / Prostate-Specific Antigen Limits: Humans / Male Language: Zh Journal: Zhonghua Yu Fang Yi Xue Za Zhi Year: 2024 Document type: Article Affiliation country: China Country of publication: China